home / stock / snanf / snanf quote
Last: | $0.22 |
---|---|
Change Percent: | 0.0% |
Open: | $0.22 |
Close: | $0.22 |
High: | $0.22 |
Low: | $0.22 |
Volume: | 3,500 |
Last Trade Date Time: | 07/16/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.22 | $0.22 | $0.22 | $0.22 | $0.22 | 3,500 | 07-16-2024 |
$0.2098 | $0.2098 | $0.2098 | $0.2098 | $0.2098 | 198 | 07-10-2024 |
$0.22 | $0 | $0.22 | $0 | $0 | 410 | 07-08-2024 |
$0.22 | $0.22 | $0.22 | $0.22 | $0.22 | 2,500 | 07-05-2024 |
$0.225 | $0 | $0.225 | $0 | $0 | 25 | 07-03-2024 |
$0.225 | $0.235 | $0.225 | $0.235 | $0.225 | 2,650 | 07-02-2024 |
$0.26 | $0.256 | $0.26 | $0.26 | $0.255 | 20,503 | 07-01-2024 |
$0.227 | $0.22 | $0.227 | $0.227 | $0.22 | 10,350 | 06-28-2024 |
$0.22 | $0 | $0.22 | $0 | $0 | 100 | 06-27-2024 |
$0.22 | $0.22 | $0.22 | $0.22 | $0.22 | 10,000 | 06-26-2024 |
$0.183 | $0.183 | $0.183 | $0.183 | $0.183 | 990 | 06-25-2024 |
$0.1957 | $0.2229 | $0.1957 | $0.2623 | $0.1957 | 89,500 | 06-21-2024 |
$0.1841 | $0.19 | $0.1841 | $0.19 | $0.1841 | 43,000 | 06-19-2024 |
$0.1841 | $0.19 | $0.1841 | $0.19 | $0.1841 | 43,000 | 06-18-2024 |
$0.185 | $0.185 | $0.185 | $0.185 | $0.185 | 800 | 06-17-2024 |
$0.185 | $0.185 | $0.185 | $0.185 | $0.185 | 10,000 | 06-14-2024 |
$0.19415 | $0.19415 | $0.19415 | $0.19415 | $0.19415 | 100 | 06-12-2024 |
$0.2022 | $0.2079 | $0.2022 | $0.2079 | $0.2022 | 500 | 06-11-2024 |
$0.1966 | $0.2047 | $0.1966 | $0.2047 | $0.1966 | 41,000 | 06-10-2024 |
$0.2155 | $0.247 | $0.2155 | $0.247 | $0.2155 | 13,968 | 06-06-2024 |
News, Short Squeeze, Breakout and More Instantly...
Halifax, Nova Scotia--(Newsfile Corp. - June 26, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona") is pleased to announce that a detailed biomarker analysis of the recently reported pre-clinical melanoma study conducted at Dalhousie University (the "Study") indicates...
Halifax, Nova Scotia--(Newsfile Corp. - June 20, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona") is pleased to announce that its targeted hyperthermia therapy ("THT") demonstrated positive results in a second preclinical cancer model. Findings just presented at the...
Halifax, Nova Scotia--(Newsfile Corp. - May 21, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona") is pleased to advise that it has appointed Dr. Carman Giacomantonio MD, MSc., FRCSC (Cav.) to be the Company's Chief Medical Officer. Dr. Giacomantonio is a practicing S...